HDAC10 deletion promotes Foxp3
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 01 2020
16 01 2020
Historique:
received:
11
09
2019
accepted:
24
12
2019
entrez:
18
1
2020
pubmed:
18
1
2020
medline:
18
11
2020
Statut:
epublish
Résumé
Foxp3
Identifiants
pubmed: 31949209
doi: 10.1038/s41598-019-57294-x
pii: 10.1038/s41598-019-57294-x
pmc: PMC6965082
doi:
Substances chimiques
FOXP3 protein, human
0
Forkhead Transcription Factors
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
424Subventions
Organisme : NIMH NIH HHS
ID : R01 MH108592
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI095276
Pays : United States
Organisme : NIH HHS
ID : R01 OD010944
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI123241
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS021328
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI073489
Pays : United States
Organisme : NIAID NIH HHS
ID : K08 AI095353
Pays : United States
Références
Feuerer, M., Hill, J. A., Mathis, D. & Benoist, C. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat. Immunol. 10, 689–695, https://doi.org/10.1038/ni.1760 (2009).
doi: 10.1038/ni.1760
pubmed: 19536194
Yano, H., Andrews, L. P., Workman, C. J. & Vignali, D. A. A. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity. Immunology, https://doi.org/10.1111/imm.13067 (2019).
doi: 10.1111/imm.13067
van Loosdregt, J. et al. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115, 965–974, https://doi.org/10.1182/blood-2009-02-207118 (2010).
doi: 10.1182/blood-2009-02-207118
pubmed: 19996091
Liu, Y., Wang, L., Han, R., Beier, U. H. & Hancock, W. W. Two lysines in the forkhead domain of foxp3 are key to T regulatory cell function. PLoS One 7, e29035, https://doi.org/10.1371/journal.pone.0029035 (2012).
doi: 10.1371/journal.pone.0029035
pubmed: 22247766
pmcid: 3256141
Wang, L. et al. Histone/protein deacetylase inhibitor therapy for enhancement of Foxp3+ T-regulatory cell function posttransplantation. Am. J. Transpl. 18, 1596–1603, https://doi.org/10.1111/ajt.14749 (2018).
doi: 10.1111/ajt.14749
Tao, R. et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299–1307, https://doi.org/10.1038/nm1652 (2007).
doi: 10.1038/nm1652
pubmed: 17922010
de Zoeten, E. F., Wang, L., Sai, H., Dillmann, W. H. & Hancock, W. W. Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology 138, 583–594, https://doi.org/10.1053/j.gastro.2009.10.037 (2010).
doi: 10.1053/j.gastro.2009.10.037
pubmed: 19879272
de Zoeten, E. F. et al. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells. Mol. Cell Biol. 31, 2066–2078, https://doi.org/10.1128/MCB.05155-11 (2011).
doi: 10.1128/MCB.05155-11
pubmed: 21444725
pmcid: 3133361
Beier, U. H. et al. Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival. Mol. Cell Biol. 31, 1022–1029, https://doi.org/10.1128/MCB.01206-10 (2011).
doi: 10.1128/MCB.01206-10
pubmed: 21199917
pmcid: 3067815
Beier, U. H. et al. Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Sci. Signal. 5, ra45, https://doi.org/10.1126/scisignal.2002873 (2012).
doi: 10.1126/scisignal.2002873
pubmed: 22715468
pmcid: 3603571
Beier, U. H. et al. Essential role of mitochondrial energy metabolism in Foxp3(+) T-regulatory cell function and allograft survival. FASEB J. 29, 2315–2326, https://doi.org/10.1096/fj.14-268409 (2015).
doi: 10.1096/fj.14-268409
pubmed: 25681462
pmcid: 4447222
Wang, L. et al. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3. J. Clin. Invest. 125, 1111–1123, https://doi.org/10.1172/JCI77088 (2015).
doi: 10.1172/JCI77088
pubmed: 25642770
pmcid: 4362235
Xiao, H. et al. HDAC5 controls the functions of Foxp3(+) T-regulatory and CD8(+) T cells. Int. J. Cancer 138, 2477–2486, https://doi.org/10.1002/ijc.29979 (2016).
doi: 10.1002/ijc.29979
pubmed: 26704363
pmcid: 5484398
Hancock, W. W. Isoform-Selective HDAC Inhibitor Therapy for Transplantation: Are We Ready for HDAC6? Transplantation 100, 1597–1598, https://doi.org/10.1097/TP.0000000000001209 (2016).
doi: 10.1097/TP.0000000000001209
pubmed: 27222931
pmcid: 4961515
Qian, H. et al. HDAC6-mediated acetylation of lipid droplet-binding protein CIDEC regulates fat-induced lipid storage. J. Clin. Invest. 127, 1353–1369, https://doi.org/10.1172/JCI85963 (2017).
doi: 10.1172/JCI85963
pubmed: 28287402
pmcid: 5373879
Lieber, A. D. et al. Loss of HDAC6 alters gut microbiota and worsens obesity. FASEB J. 33, 1098–1109, https://doi.org/10.1096/fj.201701586R (2019).
doi: 10.1096/fj.201701586R
pubmed: 30102568
Oehme, I. et al. Histone deacetylase 10 promotes autophagy-mediated cell survival. Proc. Natl Acad. Sci. USA 110, E2592–2601, https://doi.org/10.1073/pnas.1300113110 (2013).
doi: 10.1073/pnas.1300113110
pubmed: 23801752
Kao, H. Y., Lee, C. H., Komarov, A., Han, C. C. & Evans, R. M. Isolation and characterization of mammalian HDAC10, a novel histone deacetylase. J. Biol. Chem. 277, 187–193, https://doi.org/10.1074/jbc.M108931200 (2002).
doi: 10.1074/jbc.M108931200
pubmed: 11677242
Fischer, D. D. et al. Isolation and characterization of a novel class II histone deacetylase, HDAC10. J. Biol. Chem. 277, 6656–6666, https://doi.org/10.1074/jbc.M108055200 (2002).
doi: 10.1074/jbc.M108055200
pubmed: 11739383
Radhakrishnan, R. et al. Histone deacetylase 10 regulates DNA mismatch repair and may involve the deacetylation of MutS homolog 2. J. Biol. Chem. 290, 22795–22804, https://doi.org/10.1074/jbc.M114.612945 (2015).
doi: 10.1074/jbc.M114.612945
pubmed: 26221039
pmcid: 4566250
Yang, Y. et al. HDAC10 promotes lung cancer proliferation via AKT phosphorylation. Oncotarget 7, 59388–59401, https://doi.org/10.18632/oncotarget.10673 (2016).
doi: 10.18632/oncotarget.10673
pubmed: 27449083
pmcid: 5312319
Wang, B. et al. A Novel Role for Histone Deacetylase 10 (HDAC10) in the Regulation of PD-L1 Expression and Immune Tolerance Mediated By Antigen Presenting Cells (APCs). Blood 130, 3561 (2017).
Liu, Y. et al. Inhibition of p300 impairs Foxp3(+) T regulatory cell function and promotes antitumor immunity. Nat. Med. 19, 1173–1177, https://doi.org/10.1038/nm.3286 (2013).
doi: 10.1038/nm.3286
pubmed: 23955711
pmcid: 3793393
van Loosdregt, J. et al. Rapid temporal control of Foxp3 protein degradation by sirtuin-1. PLoS One 6, e19047, https://doi.org/10.1371/journal.pone.0019047 (2011).
doi: 10.1371/journal.pone.0019047
pubmed: 21533107
pmcid: 3080399
Osada, H. et al. Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients. Int. J. Cancer 112, 26–32, https://doi.org/10.1002/ijc.20395 (2004).
doi: 10.1002/ijc.20395
pubmed: 15305372
Elstrom, R. L. et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 64, 3892–3899, https://doi.org/10.1158/0008-5472.CAN-03-2904 (2004).
doi: 10.1158/0008-5472.CAN-03-2904
pubmed: 15172999
Gerriets, V. A. et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat. Immunol. 17, 1459–1466, https://doi.org/10.1038/ni.3577 (2016).
doi: 10.1038/ni.3577
pubmed: 27695003
pmcid: 5215903
Angelin, A. et al. Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments. Cell Metab. 25, 1282–1293 e1287, https://doi.org/10.1016/j.cmet.2016.12.018 (2017).
doi: 10.1016/j.cmet.2016.12.018
pubmed: 28416194
pmcid: 5462872
Geraldy, M. et al. Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated. J. Med. Chem. 62, 4426–4443, https://doi.org/10.1021/acs.jmedchem.8b01936 (2019).
doi: 10.1021/acs.jmedchem.8b01936
pubmed: 30964290
Uba, A. I. & Yelekci, K. Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors. Journal of biomolecular structure & dynamics, 1–24, https://doi.org/10.1080/07391102.2018.1521747 (2018).
doi: 10.1080/07391102.2018.1521747
Hai, Y., Shinsky, S. A., Porter, N. J. & Christianson, D. W. Histone deacetylase 10 structure and molecular function as a polyamine deacetylase. Nat. Commun. 8, 15368, https://doi.org/10.1038/ncomms15368 (2017).
doi: 10.1038/ncomms15368
pubmed: 28516954
pmcid: 5454378
Jin, Z. et al. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients. Int. J. Clin. Exp. Pathol. 7, 5872–5879 (2014).
pubmed: 25337229
pmcid: 4203200
Oehme, I., Lodrini, M., Brady, N. R. & Witt, O. Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas. Autophagy 9, 2163–2165, https://doi.org/10.4161/auto.26450 (2013).
doi: 10.4161/auto.26450
pubmed: 24145760
Ridinger, J. et al. Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance. Sci. Rep. 8, 10039, https://doi.org/10.1038/s41598-018-28265-5 (2018).
doi: 10.1038/s41598-018-28265-5
pubmed: 29968769
pmcid: 6030077
Cicenas, J. The potential role of Akt phosphorylation in human cancers. Int. J. Biol. Markers 23, 1–9 (2008).
doi: 10.1177/172460080802300101
Tanaka, A. & Sakaguchi, S. Regulatory T cells in cancer immunotherapy. Cell Res. 27, 109–118, https://doi.org/10.1038/cr.2016.151 (2017).
doi: 10.1038/cr.2016.151
pubmed: 27995907
Song, C., Zhu, S., Wu, C. & Kang, J. Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J. Biol. Chem. 288, 28021–28033, https://doi.org/10.1074/jbc.M113.498758 (2013).
doi: 10.1074/jbc.M113.498758
pubmed: 23897811
pmcid: 3784715
Gialeli, C., Theocharis, A. D. & Karamanos, N. K. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 278, 16–27, https://doi.org/10.1111/j.1742-4658.2010.07919.x (2011).
doi: 10.1111/j.1742-4658.2010.07919.x
pubmed: 21087457
Skarnes, W. C. et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474, 337–342, https://doi.org/10.1038/nature10163 (2011).
doi: 10.1038/nature10163
pubmed: 21677750
pmcid: 3572410
Akimova, T. et al. Targeting sirtuin-1 alleviates experimental autoimmune colitis by induction of Foxp3+ T-regulatory cells. Mucosal Immunol. 7, 1209–1220, https://doi.org/10.1038/mi.2014.10 (2014).
doi: 10.1038/mi.2014.10
pubmed: 24549276
pmcid: 4138288